What Estimated Average Glucose (eAG) Means
Estimated average glucose (eAG) is a calculated value that translates your HbA1c percentage into the same units (mg/dL or mmol/L) used for daily blood glucose measurements, representing your average blood glucose level over the past 2-3 months.
The Core Concept
eAG converts the HbA1c test result—which is expressed as a percentage—into glucose units that match what you see on your glucose meter. This makes it easier to understand how your HbA1c relates to your day-to-day glucose readings 1.
The conversion is based on the A1C-Derived Average Glucose (ADAG) study, which analyzed approximately 2,700 glucose measurements over 3 months per A1C measurement in 507 adults with type 1 diabetes, type 2 diabetes, and no diabetes. This study found a strong correlation (r = 0.92) between A1C and average glucose 2, 1.
How It Works in Practice
The American Diabetes Association and American Association for Clinical Chemistry determined the correlation is strong enough to justify reporting both the A1C result and the eAG result together when ordering an A1C test 2, 1.
Practical Examples:
- An A1C of 7% corresponds to an eAG of 154 mg/dL (8.6 mmol/L)
- An A1C of 8% corresponds to an eAG of 183 mg/dL (10.2 mmol/L)
- An A1C of 9% corresponds to an eAG of 212 mg/dL (11.8 mmol/L)
A calculator for converting A1C results into eAG is available at professional.diabetes.org/eAG 2, 1.
Important Limitations to Understand
eAG Is Not the Same as Daily Glucose Readings
While eAG and your daily glucose measurements use the same units, they cannot be used interchangeably 3. eAG represents an average over 2-3 months, while your meter shows real-time values. You may have an eAG of 154 mg/dL but see individual readings ranging from 80 to 250 mg/dL throughout the day.
When eAG May Be Inaccurate
eAG calculations can be misleading in several situations 2, 1:
- Conditions affecting red blood cell turnover: hemolytic anemia, glucose-6-phosphate dehydrogenase deficiency, recent blood transfusion, use of erythropoiesis-stimulating drugs, end-stage kidney disease, pregnancy
- Hemoglobin variants: particularly in individuals with sickle cell disease (HbSS) or other homozygous variants who lack HbA
- Ethnic differences: Studies show African Americans may have higher A1C values than non-Hispanic Whites at the same average glucose level, though Afro-Caribbean individuals showed the opposite pattern 2, 4
Relationship to Glycemic Control
The correlation between eAG and fasting glucose depends on how well controlled your diabetes is 5. The relationship is stronger when glucose levels are higher (poorly controlled diabetes) and weaker when glucose is well-controlled. Only 81% of diabetic patients have fasting glucose lower than their eAG 5.
Clinical Value
eAG helps bridge the gap between:
- The long-term glycemic control measure (A1C) that predicts complications
- The daily glucose values you monitor for immediate management decisions
This translation enhances patient understanding and engagement with diabetes management by expressing both metrics in familiar glucose units 6. However, eAG does not capture glycemic variability or hypoglycemia—you still need actual glucose monitoring for day-to-day management 1.
Modern Context
The eAG data comes from a 2008 study using early continuous glucose monitoring systems and capillary glucose measurements. It remains unclear how well these estimates apply to modern CGM systems, which may differ in calibration, accuracy, and the lag time between interstitial and venous glucose 1.
For individuals with conditions that interfere with A1C interpretation, alternative monitoring approaches should be used, including self-monitoring of blood glucose, CGM, or glycated serum protein assays like fructosamine or glycated albumin 1.